{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:37:58Z","timestamp":1782999478751,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["(#602420"],"award-info":[{"award-number":["(#602420"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.vaccine.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T09:17:33Z","timestamp":1547630253000},"page":"919-925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis"],"prefix":"10.1016","volume":"37","author":[{"given":"Ellen","family":"Strijbos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-0390","authenticated-orcid":false,"given":"Martijn R.","family":"Tannemaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Alleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.P.","family":"de Meel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap A.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus F.","family":"Rimmelzwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.01.007_b0005","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2019.01.007_b0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrrheum.2011.14","article-title":"Immunology: prevention of infections in patients with autoimmune diseases","volume":"7","author":"Meyer-Olson","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2019.01.007_b0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrrheum.2014.206","article-title":"Vaccination of patients with autoimmune inflammatory rheumatic diseases","volume":"11","author":"Westra","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2019.01.007_b0020","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","author":"Gilhus","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.vaccine.2019.01.007_b0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/mus.22077","article-title":"Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance","volume":"43","author":"Auriel","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.vaccine.2019.01.007_b0030","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21440","article-title":"Safety of influenza vaccination in patients with myasthenia gravis: a population-based study","volume":"40","author":"Zinman","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.vaccine.2019.01.007_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","article-title":"The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis","volume":"13","author":"Seok","year":"2017","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.vaccine.2019.01.007_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2018.01.007","article-title":"Acetylcholine receptor antibody titers and clinical course after influenza vaccination in patients with myasthenia gravis: a double-blind randomized controlled trial (ProPATIent-Trial)","author":"Tackenberg","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2019.01.007_b0045","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1016\/j.vaccine.2017.09.078","article-title":"A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis","volume":"35","author":"Strijbos","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.007_b0050","first-page":"A7574","article-title":"Influenza vaccination in immunocompromised patients","volume":"158","author":"Klinkenberg","year":"2014","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.vaccine.2019.01.007_b0055","doi-asserted-by":"crossref","first-page":"212293","DOI":"10.7573\/dic.212293","article-title":"Influenza vaccination: key facts for general practitioners in Europe-a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands","volume":"5","author":"Kassianos","year":"2016","journal-title":"Drugs in Context"},{"key":"10.1016\/j.vaccine.2019.01.007_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.vaccine.2019.01.007_b0065","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.vaccine.2003.11.046","article-title":"Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients","volume":"22","author":"Vogtlander","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.007_b0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.2012.06817.x","article-title":"The myasthenia gravis\u2013specific activities of daily living profile","volume":"1274","author":"Muppidi","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2019.01.007_b0075","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","article-title":"Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity","volume":"64","author":"Bedlack","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2019.01.007_b0080","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","article-title":"The MG Composite: a valid and reliable outcome measure for myasthenia gravis","volume":"74","author":"Burns","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2019.01.007_b0085","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2019.01.007_b0090","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.vaccine.2019.01.007_b0095","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2019.01.007_b0100","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2005.043943","article-title":"Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease","volume":"65","author":"Holvast","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2019.01.007_b0105","first-page":"2555","article-title":"Specific antibody response after influenza immunization in systemic lupus erythematosus","volume":"29","author":"Abu-Shakra","year":"2002","journal-title":"J Rheumatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19300386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T17:06:13Z","timestamp":1570554373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19300386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0264410X19300386"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}